Literature DB >> 28850636

Allogeneic Descemet's Membrane Transplantation Enhances Corneal Endothelial Monolayer Formation and Restores Functional Integrity Following Descemet's Stripping.

Maninder Bhogal1,2,3, Chan N Lwin1, Xin-Yi Seah1, Gary Peh1,4, Jodhbir S Mehta1,2,3,4,5.   

Abstract

Purpose: To characterize the differences in corneal endothelial wound healing in the presence or absence of Descemet's membrane (DM), in vivo.
Methods: New-Zealand white rabbits were subjected to 7-mm endothelial wound either by scraping (n = 8; DM intact), peeling (n = 6; DM removed), or a combinatory scrape/peel wound (n = 6). In a second experiment, rabbits underwent peel wound with immediate transplantation of pure decellularized human DM (n = 4). In vivo endothelial migration was assessed via trypan blue staining. Recovery of corneal clarity and thickness was performed by using slit-lamp biomicroscopy and optical coherence tomography. Cell proliferation, phenotype, and morphology were assessed by using immunofluorescence and scanning electron microscopy.
Results: In vivo wound closure was faster in the presence of DM; 25.4% ± 1.4%/d versus 5.5% ± 0.6%/d (P < 0.0001). At day 8, complete wound closure was seen in all of the scrape samples but none of the peel group, with wound closure preceding clinical recovery by approximately 6 days in the scrape group. Endothelial cells in the scraped areas reformed functional monolayers capable of restoring corneal thickness and transparency whilst those in the peeled area underwent mesenchymal-like transformation resulting in scar formation. Transplanting decellularized DM in animals receiving a peel wound resulted in clarity and thickness comparable to the scrape group. Endothelial proliferation (Ki67 +ve cells) was higher in scraped versus peeled areas: 54.7% ± 3.5% vs. 8.8% ± 0.7%, (P < 0.01). Conclusions: The presence of DM promoted endothelial wound healing, proliferation, and maintenance of a normal phenotype. DM transplantation recovered the abnormal peel phenotype back to that observed after endothelial scraping.

Entities:  

Mesh:

Year:  2017        PMID: 28850636     DOI: 10.1167/iovs.17-22106

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  13 in total

Review 1.  Corneal injury: Clinical and molecular aspects.

Authors:  Brayden Barrientez; Sarah E Nicholas; Amy Whelchel; Rabab Sharif; Jesper Hjortdal; Dimitrios Karamichos
Journal:  Exp Eye Res       Date:  2019-06-22       Impact factor: 3.467

2.  Targeting non-muscle myosin II promotes corneal endothelial migration through regulating lamellipodial dynamics.

Authors:  Wei-Ting Ho; Jung-Shen Chang; San-Fang Chou; Wei-Lun Hwang; Po-Jen Shih; Shu-Wen Chang; Muh-Hwa Yang; Tzuu-Shuh Jou; I-Jong Wang
Journal:  J Mol Med (Berl)       Date:  2019-07-13       Impact factor: 4.599

Review 3.  Fuchs endothelial corneal dystrophy and corneal endothelial diseases: East meets West.

Authors:  Y Q Soh; Viridiana Kocaba; Mauricio Pinto; Jodhbir S Mehta
Journal:  Eye (Lond)       Date:  2019-07-02       Impact factor: 3.775

4.  Super-resolution imaging of flat-mounted whole mouse cornea.

Authors:  Zhen Cai; Yang Zhang; Zheyuan Zhang; Ki-Hee Song; Lisa Beckmann; Ali Djalilian; Cheng Sun; Hao F Zhang
Journal:  Exp Eye Res       Date:  2021-02-18       Impact factor: 3.467

5.  Quantification of the Posterior Cornea Using Swept Source Optical Coherence Tomography.

Authors:  Stephen Wahlig; Gary Hin-Fai Yam; Wesley Chong; Xin-Yi Seah; Viridiana Kocaba; Marcus Ang; Hla Myint Htoon; Tin A Tun; Hon Shing Ong; Jodhbir S Mehta
Journal:  Transl Vis Sci Technol       Date:  2018-09-04       Impact factor: 3.283

6.  Functional Evaluation of Two Corneal Endothelial Cell-Based Therapies: Tissue-Engineered Construct and Cell Injection.

Authors:  Gary S L Peh; Hon Shing Ong; Khadijah Adnan; Heng-Pei Ang; Chan N Lwin; Xin-Yi Seah; Shu-Jun Lin; Jodhbir S Mehta
Journal:  Sci Rep       Date:  2019-04-15       Impact factor: 4.379

Review 7.  Regenerative capacity of the corneal transition zone for endothelial cell therapy.

Authors:  Nicole Ming Sie; Gary Hin-Fai Yam; Yu Qiang Soh; Matthew Lovatt; Deepinder Dhaliwal; Viridiana Kocaba; Jodhbir S Mehta
Journal:  Stem Cell Res Ther       Date:  2020-12-04       Impact factor: 6.832

Review 8.  Fuchs endothelial corneal dystrophy: The vicious cycle of Fuchs pathogenesis.

Authors:  Stephan Ong Tone; Viridiana Kocaba; Myriam Böhm; Adam Wylegala; Tomas L White; Ula V Jurkunas
Journal:  Prog Retin Eye Res       Date:  2020-05-08       Impact factor: 21.198

Review 9.  Regenerative medicine in Fuchs' endothelial corneal dystrophy.

Authors:  Amy E Yuan; Roberto Pineda
Journal:  Taiwan J Ophthalmol       Date:  2020-07-06

Review 10.  New Horizons in the Treatment of Corneal Endothelial Dysfunction.

Authors:  Carlos Rocha-de-Lossada; Rahul Rachwani-Anil; Davide Borroni; José-María Sánchez-González; Raquel Esteves-Marques; Fernando-Luis Soler-Ferrández; Jose-Antonio Gegúndez-Fernández; Vito Romano; Eitan Livny; Marina Rodríguez Calvo-de-Mora
Journal:  J Ophthalmol       Date:  2021-07-09       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.